|
|
|
|
|
|
|
|
132nd MAINE LEGISLATURE |
|
|
LD 1100 |
|
LR 629(02) |
|
|
|
An Act to Clarify
the Requirements for Accessing Nonformulary Drugs and Drugs Used to Treat
Serious Mental Illness |
|
Fiscal Note for
Bill as Amended by Committee Amendment " " |
|
Committee: Health Coverage, Insurance and
Financial Services |
|
Fiscal Note Required: Yes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Note |
|
|
|
|
|
|
|
Potential current biennium cost increase - All Funds |
|
|
|
|
|
|
|
Fiscal Detail
and Notes |
|
|
|
|
|
|
This bill
clarifies requirements for accessing nonformulary drugs related to treating
serious mental illness and eliminates a requirement that an enrollee in a
health plan gain access to a clinically appropriate drug not otherwise
covered by the health plan. The bill also clarifies that a carrier must
approve a prior authorization for an equivalent nonformulary drug in the
instance of a shortage of the formulary drug with no formulary equivalent.
This will potentially increase costs to the State Employee Health Plan. A
more precise estimate of the fiscal impact cannot be determined because it is
not possible to predict hypothetical drug shortages, the number of impacted
plan members, and subsequent costs. |
|
|
|
|
|
|
|